Correlation Between Cyteir Therapeutics and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and AnaptysBio, you can compare the effects of market volatilities on Cyteir Therapeutics and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and AnaptysBio.
Diversification Opportunities for Cyteir Therapeutics and AnaptysBio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cyteir and AnaptysBio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and AnaptysBio go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and AnaptysBio
If you would invest (100.00) in Cyteir Therapeutics on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Cyteir Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Cyteir Therapeutics vs. AnaptysBio
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
AnaptysBio |
Cyteir Therapeutics and AnaptysBio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and AnaptysBio
The main advantage of trading using opposite Cyteir Therapeutics and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
AnaptysBio vs. Beam Therapeutics | AnaptysBio vs. Editas Medicine | AnaptysBio vs. Caribou Biosciences | AnaptysBio vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |